|
US2750393A
(en)
*
|
1954-12-01 |
1956-06-12 |
Sterling Drug Inc |
Iodinated 5-henzamidotetrazoles and preparation thereof
|
|
US2967194A
(en)
*
|
1958-05-15 |
1961-01-03 |
Pennsalt Chemicals Corp |
4-trifluoromethylsalicylamides
|
|
FR1526074A
(fr)
|
1967-03-22 |
1968-05-24 |
Rech S Ind S O R I Soc D |
Méthoxy-phényl-amino-2-thiazoles, leurs amides et leurs procédés de préparation
|
|
GB1352415A
(en)
|
1970-05-03 |
1974-05-08 |
Boots Co Ltd |
Esters of substituted nicotine acids
|
|
FR2088019A1
(en)
|
1970-05-08 |
1972-01-07 |
Rabot Ets David |
Esters of 2 and 6-substituted nicotinic acids - with vasomotor active
|
|
CS173097B1
(enExample)
|
1972-12-01 |
1977-02-28 |
|
|
|
GB1400540A
(en)
*
|
1972-12-06 |
1975-07-16 |
Smith Kline French Lab |
Salicylamides and compositions thereof
|
|
US4009174A
(en)
*
|
1972-12-08 |
1977-02-22 |
The Boots Company Limited |
Esters of substituted nicotinic acids
|
|
GB1437800A
(en)
*
|
1973-08-08 |
1976-06-03 |
Phavic Sprl |
Derivatives of 2-benzamido-5-nitro-thiazoles
|
|
JPS5734314B2
(enExample)
|
1973-12-22 |
1982-07-22 |
|
|
|
GB1561350A
(en)
*
|
1976-11-05 |
1980-02-20 |
May & Baker Ltd |
Benzamide derivatives
|
|
FR2344284A1
(fr)
*
|
1976-03-17 |
1977-10-14 |
Cerm Cent Europ Rech Mauvernay |
Nouveaux composes tricycliques a cycle furannique et leur application comme antidepresseurs
|
|
GB1588242A
(en)
|
1977-10-28 |
1981-04-23 |
May & Baker Ltd |
N-(tetrazol-5-yl)-salicylamide derivatives
|
|
US4474792A
(en)
*
|
1979-06-18 |
1984-10-02 |
Riker Laboratories, Inc. |
N-Tetrazolyl benzamides and anti-allergic use thereof
|
|
JPS5721320A
(en)
|
1980-07-11 |
1982-02-04 |
Chugai Pharmaceut Co Ltd |
Blood sugar level depressing agent
|
|
JPS5775962A
(en)
|
1980-10-29 |
1982-05-12 |
Shionogi & Co Ltd |
2-alkoxybenzamide derivative
|
|
FR2493848B2
(fr)
*
|
1980-11-07 |
1986-05-16 |
Delalande Sa |
Nouveaux derives des nor-tropane et granatane, leur procede de preparation et leur application en therapeutique
|
|
JPS5869812A
(ja)
|
1981-10-22 |
1983-04-26 |
Chugai Pharmaceut Co Ltd |
血糖降下剤
|
|
JPS59139357A
(ja)
*
|
1983-01-28 |
1984-08-10 |
Torii Yakuhin Kk |
アミジン誘導体
|
|
JPS61205937A
(ja)
|
1985-03-09 |
1986-09-12 |
Konishiroku Photo Ind Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
JPS62142168A
(ja)
|
1985-10-16 |
1987-06-25 |
Mitsubishi Chem Ind Ltd |
チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
|
|
JPS62158252A
(ja)
|
1985-12-28 |
1987-07-14 |
Kirin Brewery Co Ltd |
４−アミノピリジンベンズアミド誘導体
|
|
CA1327358C
(en)
|
1987-11-17 |
1994-03-01 |
Morio Fujiu |
Fluoro cytidine derivatives
|
|
JP2852659B2
(ja)
|
1988-03-03 |
1999-02-03 |
富山化学工業株式会社 |
ピペラジン誘導体およびその塩
|
|
DE3822449A1
(de)
|
1988-07-02 |
1990-01-04 |
Henkel Kgaa |
Oxidationshaarfaerbemittel mit neuen kupplern
|
|
JPH03181465A
(ja)
|
1989-12-11 |
1991-08-07 |
Takeda Chem Ind Ltd |
キノリン誘導体
|
|
US6344213B1
(en)
|
1996-03-29 |
2002-02-05 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
JPH04300874A
(ja)
|
1991-03-29 |
1992-10-23 |
Tsumura & Co |
新規２，４−ジアミノ−１，３，５−トリアジン誘導体
|
|
JPH04300832A
(ja)
|
1991-03-29 |
1992-10-23 |
Tsumura & Co |
２，４−ジアミノ−１，３，５−トリアジン誘導体を有 効成分とするロイコトリエン拮抗剤
|
|
US5258407A
(en)
*
|
1991-12-31 |
1993-11-02 |
Sterling Winthrop Inc. |
3,4-disubstituted phenols-immunomodulating agents
|
|
US5466715A
(en)
*
|
1991-12-31 |
1995-11-14 |
Sterling Winthrop Inc. |
3,4-disubstituted phenols-immunomodulating agents
|
|
US5273986A
(en)
*
|
1992-07-02 |
1993-12-28 |
Hoffmann-La Roche Inc. |
Cycloalkylthiazoles
|
|
JPH0627025A
(ja)
|
1992-07-06 |
1994-02-04 |
Toto Ltd |
分子認識機能膜及びこれを用いたセンサー
|
|
EP0612319A1
(en)
|
1992-08-20 |
1994-08-31 |
Otsuka Pharmaceutical Co., Ltd. |
Benzoheterocyclic compounds as oxytocin and vasopressin antagonists
|
|
ATE234270T1
(de)
|
1992-12-02 |
2003-03-15 |
Pfizer |
Cathecoldiether als selektive pde iv hemmungsmittel
|
|
EP0619116A3
(en)
|
1993-04-05 |
1994-11-23 |
Hoechst Japan |
Use of synthetic retinoids for osteopathy.
|
|
GB9307527D0
(en)
|
1993-04-13 |
1993-06-02 |
Fujisawa Pharmaceutical Co |
New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
|
|
GB9401460D0
(en)
|
1994-01-26 |
1994-03-23 |
Rhone Poulenc Rorer Ltd |
Compositions of matter
|
|
WO1995035298A1
(en)
|
1994-06-21 |
1995-12-28 |
Otsuka Pharmaceutical Factory, Inc. |
PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE
|
|
US5661153A
(en)
*
|
1994-07-19 |
1997-08-26 |
Japan Energy Corporation |
1-arylpyrimidine derivatives and pharmaceutical use thereof
|
|
US5792109A
(en)
|
1994-09-01 |
1998-08-11 |
Leland L. Ladd |
Irrigation pump and system
|
|
GB9420557D0
(en)
|
1994-10-12 |
1994-11-30 |
Zeneca Ltd |
Aromatic compounds
|
|
JPH08143565A
(ja)
|
1994-11-16 |
1996-06-04 |
Fujisawa Pharmaceut Co Ltd |
ベンズアミド化合物
|
|
US5510478A
(en)
*
|
1994-11-30 |
1996-04-23 |
American Home Products Corporation |
2-arylamidothiazole derivatives with CNS activity
|
|
US5672750A
(en)
*
|
1994-12-16 |
1997-09-30 |
Eastman Chemical Company |
Preparation of aromatic amides from carbon monoxide, an amine and an aromatic chloride
|
|
US5962682A
(en)
|
1994-12-20 |
1999-10-05 |
Hoffmann-La Roche Inc. |
Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
|
|
AR002459A1
(es)
|
1995-01-17 |
1998-03-25 |
American Cyanamid Co |
Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion.
|
|
US5753648A
(en)
|
1995-01-17 |
1998-05-19 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
US5700796A
(en)
|
1995-01-17 |
1997-12-23 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
US5536718A
(en)
|
1995-01-17 |
1996-07-16 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
US5849735A
(en)
*
|
1995-01-17 |
1998-12-15 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
US5696112A
(en)
|
1995-01-17 |
1997-12-09 |
American Cyanamid Company |
Fused heterocyclic azepines as vasopressin antagonists
|
|
US5532235A
(en)
|
1995-01-17 |
1996-07-02 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
JPH08301760A
(ja)
|
1995-05-10 |
1996-11-19 |
Shiseido Co Ltd |
皮膚外用剤
|
|
DK0870765T3
(da)
|
1995-05-18 |
2004-02-23 |
Zeria Pharm Co Ltd |
Aminothiazolderivat, lægemiddel indeholdende samme og mellemprodukt til fremstilling af forbindelsen
|
|
JP3168915B2
(ja)
|
1995-05-25 |
2001-05-21 |
田辺製薬株式会社 |
医薬組成物
|
|
GB9511694D0
(en)
|
1995-06-09 |
1995-08-02 |
Fujisawa Pharmaceutical Co |
Benzamide derivatives
|
|
US5712270A
(en)
*
|
1995-11-06 |
1998-01-27 |
American Home Products Corporation |
2-arylamidothiazole derivatives with CNS activity
|
|
JP3735741B2
(ja)
|
1995-11-24 |
2006-01-18 |
株式会社大塚製薬工場 |
縮環ピリミジン誘導体
|
|
GB9526558D0
(en)
|
1995-12-27 |
1996-02-28 |
Fujisawa Pharmaceutical Co |
Heterobicyclic derivatives
|
|
ATE228518T1
(de)
|
1996-06-06 |
2002-12-15 |
Otsuka Pharma Co Ltd |
Amid derivate
|
|
JPH10101672A
(ja)
|
1996-08-06 |
1998-04-21 |
Otsuka Pharmaceut Factory Inc |
アデノシン増強剤
|
|
JPH10101671A
(ja)
|
1996-08-08 |
1998-04-21 |
Otsuka Pharmaceut Factory Inc |
一酸化窒素合成酵素阻害剤
|
|
AUPO395396A0
(en)
*
|
1996-12-02 |
1997-01-02 |
Fujisawa Pharmaceutical Co., Ltd. |
Benzamide derivatives
|
|
FR2757852B1
(fr)
*
|
1996-12-31 |
1999-02-19 |
Cird Galderma |
Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations
|
|
JPH10212271A
(ja)
|
1997-01-31 |
1998-08-11 |
Zeria Pharmaceut Co Ltd |
Ｎ−置換ベンゾイルアミン誘導体、それを含有する医薬及び該化合物の製造中間体
|
|
DK0993831T3
(da)
|
1997-02-07 |
2008-03-25 |
Emisphere Tech Inc |
Forbindelser og præparater til tilförsel af aktive stoffer
|
|
JPH10338658A
(ja)
|
1997-04-08 |
1998-12-22 |
Hoechst Marion Roussel Kk |
レチノイド作用調節剤
|
|
JPH1129480A
(ja)
|
1997-05-12 |
1999-02-02 |
Otsuka Pharmaceut Factory Inc |
縮環ピリミジン誘導体を含有する医薬組成物
|
|
DE69826286T2
(de)
*
|
1997-06-27 |
2005-11-24 |
Fujisawa Pharmaceutical Co., Ltd. |
Derivate mit einem aromatischen ring
|
|
EP0995742A4
(en)
|
1997-06-27 |
2004-08-25 |
Fujisawa Pharmaceutical Co |
SULPHONAMIDE COMPOUNDS AND THEIR MEDICAL USE
|
|
US6613942B1
(en)
*
|
1997-07-01 |
2003-09-02 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
US6114483A
(en)
|
1997-08-27 |
2000-09-05 |
E. I. Du Pont De Nemours And Company |
Polymerization of olefins
|
|
JPH11171848A
(ja)
|
1997-09-26 |
1999-06-29 |
Fujirebio Inc |
芳香族アミド誘導体
|
|
US6297239B1
(en)
|
1997-10-08 |
2001-10-02 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
PT1025088E
(pt)
|
1997-10-22 |
2002-01-30 |
Astrazeneca Ab |
Derivados de imidazole e sua utilizacao como inibidores de farnesil proteino transferase
|
|
CA2309331A1
(en)
|
1997-11-12 |
1999-05-20 |
Institute Of Medicinal Molecular Design, Inc. |
Agent acting on retinoid receptor
|
|
WO1999026944A1
(en)
|
1997-11-21 |
1999-06-03 |
Astrazeneka Uk Limited |
New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists
|
|
GB9725298D0
(en)
|
1997-11-28 |
1998-01-28 |
Zeneca Ltd |
Insecticidal thiazole derivatives
|
|
ATE260103T1
(de)
|
1997-12-19 |
2004-03-15 |
Schering Ag |
Ortho-anthranilamide derivate als antikoagulantien
|
|
ES2317688T3
(es)
*
|
1998-01-29 |
2009-04-16 |
Amgen Inc. |
Moduladores ppar-gamma.
|
|
JP3937367B2
(ja)
|
1998-02-05 |
2007-06-27 |
株式会社大塚製薬工場 |
一酸化窒素合成酵素阻害剤
|
|
JPH11292879A
(ja)
|
1998-04-08 |
1999-10-26 |
Otsuka Pharmaceut Factory Inc |
カルボキサミド誘導体
|
|
DE19816780A1
(de)
*
|
1998-04-16 |
1999-10-21 |
Bayer Ag |
Substituierte 2-Oxo-alkansäure-[2-(indol-3-yl)-ethyl]amide
|
|
GB9811969D0
(en)
*
|
1998-06-03 |
1998-07-29 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
DE19830431A1
(de)
|
1998-07-08 |
2000-01-13 |
Hoechst Marion Roussel De Gmbh |
Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren
|
|
US6197798B1
(en)
*
|
1998-07-21 |
2001-03-06 |
Novartis Ag |
Amino-benzocycloalkane derivatives
|
|
JP4191825B2
(ja)
|
1998-09-10 |
2008-12-03 |
あすか製薬株式会社 |
５−アミノイソキサゾール誘導体
|
|
GB9823871D0
(en)
|
1998-10-30 |
1998-12-23 |
Pharmacia & Upjohn Spa |
2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
|
|
JP2002533454A
(ja)
|
1998-12-23 |
2002-10-08 |
イーライ・リリー・アンド・カンパニー |
芳香族アミド類
|
|
WO2000046203A2
(en)
|
1999-02-04 |
2000-08-10 |
Millennium Pharmaceuticals, Inc. |
G-protein coupled heptahelical receptor binding compounds and methods of use thereof
|
|
US6610846B1
(en)
*
|
1999-03-29 |
2003-08-26 |
Hoffman-La Roche Inc. |
Heteroaromatic glucokinase activators
|
|
RU2242469C2
(ru)
*
|
1999-03-29 |
2004-12-20 |
Ф.Хоффманн-Ля Рош Аг |
Активаторы глюкокиназы
|
|
US6320050B1
(en)
*
|
1999-03-29 |
2001-11-20 |
Hoffmann-La Roche Inc. |
Heteroaromatic glucokinase activators
|
|
MXPA01009814A
(es)
|
1999-03-29 |
2002-04-24 |
Hoffmann La Roche |
Activadores de la glucoquinasa.
|
|
ES2437103T3
(es)
|
1999-06-30 |
2014-01-08 |
Amgen Inc. |
Compuestos para la modulacion de la actividad de PPAR gamma
|
|
NZ517694A
(en)
|
1999-08-13 |
2005-03-24 |
Vertex Pharma |
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
|
|
CA2382789A1
(en)
|
1999-08-27 |
2001-03-08 |
Sugen, Inc. |
Phosphate mimics and methods of treatment using phosphatase inhibitors
|
|
GB9921684D0
(en)
|
1999-09-15 |
1999-11-17 |
Zeneca Ltd |
Assays
|
|
BR0014076A
(pt)
|
1999-09-17 |
2002-10-15 |
Millennium Pharm Inc |
Benzamidas e inibidores correlatos do fator xa
|
|
JP4831907B2
(ja)
|
1999-10-08 |
2011-12-07 |
アフィニアム・ファーマシューティカルズ・インコーポレイテッド |
ＦａｂＩ阻害剤
|
|
RU2002111660A
(ru)
|
1999-11-04 |
2003-11-27 |
Орто-Макнейл Фармасьютикал, Инк. (Us) |
Непептидные замещенные бензотиазепины в качестве антагонистов вазопрессина
|
|
WO2001035950A2
(en)
*
|
1999-11-18 |
2001-05-25 |
Centaur Pharmaceuticals, Inc. |
Benzamide therapeutics and methods for treating inflammatory bowel disease
|
|
US6353111B1
(en)
|
1999-12-15 |
2002-03-05 |
Hoffmann-La Roche Inc. |
Trans olefinic glucokinase activators
|
|
DK1259485T3
(da)
*
|
2000-02-29 |
2006-04-10 |
Millennium Pharm Inc |
Benzamider og beslægtede inhibitorer for faktor Xa
|
|
EP1132381A1
(en)
|
2000-03-08 |
2001-09-12 |
Cermol S.A. |
Ester derivatives of dimethylpropionic acid and pharmaceutical compositions containing them
|
|
AU776053B2
(en)
|
2000-03-31 |
2004-08-26 |
Astellas Pharma Inc. |
Diazepan derivatives or salts thereof
|
|
US6534651B2
(en)
*
|
2000-04-06 |
2003-03-18 |
Inotek Pharmaceuticals Corp. |
7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
|
|
MXPA02010746A
(es)
|
2000-05-03 |
2003-03-10 |
Hoffmann La Roche |
Activadores de la glucocinasa que contienen hidantoina.
|
|
KR100502033B1
(ko)
*
|
2000-05-03 |
2005-07-25 |
에프. 호프만-라 로슈 아게 |
알키닐 페닐 헤테로방향족 글루코키나제 활성제
|
|
MXPA02010795A
(es)
|
2000-05-08 |
2003-03-27 |
Hoffmann La Roche |
Activadores de glucocinasa de fenilamida sustituida por para-amino.
|
|
DK1282611T3
(da)
|
2000-05-08 |
2005-02-14 |
Hoffmann La Roche |
Substituerede phenylacetatamider og anvendelse deraf som glucokinaseaktivatorer
|
|
CZ302982B6
(cs)
|
2000-06-28 |
2012-02-01 |
Amgen Inc. |
3-Chinolinylfenylsulfonamidová sloucenina, tato sloucenina pro použití jako lécivo a použití této slouceniny pri výrobe léciva
|
|
PT1305301E
(pt)
|
2000-07-20 |
2005-09-30 |
Hoffmann La Roche |
Benzeno-acetamidas alfa-acilo e alfa-heteroatomo-substituidas activadoras da glucocinase
|
|
US6369232B1
(en)
|
2000-08-15 |
2002-04-09 |
Hoffmann-La Roche Inc. |
Tetrazolyl-phenyl acetamide glucokinase activators
|
|
WO2002024682A1
(en)
|
2000-09-25 |
2002-03-28 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
|
|
US20040077690A1
(en)
|
2000-09-29 |
2004-04-22 |
Bing-Yan Zhu |
Quaternary amidino based inhibitors of factor xa
|
|
WO2002026718A2
(en)
|
2000-09-29 |
2002-04-04 |
Millennium Pharmaceutical, Inc. |
Bicyclic pyrimidin-4-one based inhibitors of factor xa
|
|
CN1478077A
(zh)
|
2000-10-05 |
2004-02-25 |
����ҩƷ��ҵ��ʽ���� |
作为apo b分泌抑制剂的苯甲酰胺化合物
|
|
EP1336605B1
(en)
|
2000-11-22 |
2006-04-12 |
Astellas Pharma Inc. |
Substituted phenol derivatives or salts thereof as inhibitors of coagulation factor x
|
|
AU2002221902B2
(en)
|
2000-12-06 |
2006-11-23 |
F. Hoffmann-La Roche Ag |
Fused heteroaromatic glucokinase activators
|
|
US6482951B2
(en)
|
2000-12-13 |
2002-11-19 |
Hoffmann-La Roche Inc. |
Isoindolin-1-one glucokinase activators
|
|
GB0031301D0
(en)
|
2000-12-21 |
2001-01-31 |
Ici Plc |
Process for the production of fluoromethyl hexafluoroisopropyl ether
|
|
EP1344525A4
(en)
*
|
2000-12-22 |
2005-05-25 |
Ishihara Sangyo Kaisha |
ANILINE DERIVATIVES OR ITS SALTS AND CYTOKINE PRODUCTION INHIBITORS CONTAINING THEM
|
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
|
EP1357116A4
(en)
|
2001-02-02 |
2005-06-01 |
Yamanouchi Pharma Co Ltd |
2-ACYLAMINOTHIAZOLE DERIVATIVE OR SALT THEREOF
|
|
TWI243164B
(en)
|
2001-02-13 |
2005-11-11 |
Aventis Pharma Gmbh |
Acylated indanyl amines and their use as pharmaceuticals
|
|
DE60221505D1
(de)
|
2001-03-30 |
2007-09-13 |
Millennium Pharm Inc |
FAKTOR Xa BENZAMIDIN INHIBITOREN
|
|
SE0102300D0
(sv)
|
2001-06-26 |
2001-06-26 |
Astrazeneca Ab |
Compounds
|
|
SE0102299D0
(sv)
|
2001-06-26 |
2001-06-26 |
Astrazeneca Ab |
Compounds
|
|
EP1431267A4
(en)
*
|
2001-08-09 |
2004-12-22 |
Ono Pharmaceutical Co |
COMPOUNDS DERIVED FROM CARBOXYLIC ACID AND MEDICAMENTS COMPRISING SUCH COMPOUNDS AS ACTIVE INGREDIENT
|
|
MY142967A
(en)
|
2001-08-13 |
2011-01-31 |
Du Pont |
Method for controlling particular insect pests by applying anthranilamide compounds
|
|
SE0102764D0
(sv)
|
2001-08-17 |
2001-08-17 |
Astrazeneca Ab |
Compounds
|
|
DE60218493D1
(de)
|
2001-09-12 |
2007-04-12 |
Pharmacia & Upjohn Co Llc |
Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
|
|
TW200724033A
(en)
|
2001-09-21 |
2007-07-01 |
Du Pont |
Anthranilamide arthropodicide treatment
|
|
ES2329881T3
(es)
|
2001-09-21 |
2009-12-02 |
Bristol-Myers Squibb Company |
Compuestos que contienen lactama y derivados de los mismos como inhibidores del factor xa.
|
|
US7544690B2
(en)
|
2001-10-01 |
2009-06-09 |
Taisho Pharmaceutical Co., Ltd. |
MCH receptor antagonists
|
|
EP1453541A1
(en)
|
2001-12-03 |
2004-09-08 |
Novo Nordisk A/S |
Use of a glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetes
|
|
EP1336607A1
(en)
|
2002-02-19 |
2003-08-20 |
Novo Nordisk A/S |
Amide derivatives as glucokinase activators
|
|
AR037641A1
(es)
|
2001-12-05 |
2004-11-17 |
Tularik Inc |
Moduladores de inflamacion
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
DE10161765A1
(de)
*
|
2001-12-15 |
2003-07-03 |
Bayer Cropscience Gmbh |
Substituierte Phenylderivate
|
|
US6911545B2
(en)
|
2001-12-19 |
2005-06-28 |
Hoffman-La Roche Inc. |
Crystals of glucokinase and methods of growing them
|
|
US20030171411A1
(en)
|
2001-12-21 |
2003-09-11 |
Kodra Janos Tibor |
Amide derivatives as therapeutic agents
|
|
GB0202873D0
(en)
|
2002-02-07 |
2002-03-27 |
Novartis Ag |
Organic compounds
|
|
EP1496052B1
(en)
|
2002-03-26 |
2009-08-05 |
Banyu Pharmaceutical Co., Ltd. |
Novel aminobenzamide derivative
|
|
CN100357283C
(zh)
|
2002-04-02 |
2007-12-26 |
中国科学院上海药物研究所 |
一类甲硫氨酰氨肽酶抑制剂
|
|
AU2003232204B8
(en)
|
2002-04-26 |
2009-07-30 |
F. Hoffmann-La Roche Ag |
Substituted phenylacetamides and their use as glucokinase activators
|
|
JPWO2003097824A1
(ja)
|
2002-05-16 |
2005-09-15 |
萬有製薬株式会社 |
グルコキナーゼタンパク質の結晶、及びその結晶を用いたドラッグデザイン方法
|
|
WO2004002481A1
(en)
|
2002-06-27 |
2004-01-08 |
Novo Nordisk A/S |
Aryl carbonyl derivatives as therapeutic agents
|
|
EP1541563A4
(en)
|
2002-07-10 |
2007-11-07 |
Ono Pharmaceutical Co |
ANTAGONIST OF CCR4 AND CORRESPONDING MEDICINAL USE
|
|
WO2004022536A1
(en)
|
2002-09-04 |
2004-03-18 |
Glenmark Pharmaceuticals Limited |
New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
|
|
JP2006509774A
(ja)
|
2002-10-03 |
2006-03-23 |
ノバルティス アクチエンゲゼルシャフト |
２型糖尿病の処置において有用なグルコキナーゼアクチベーターとしての置換（チアゾール−２−イル）−アミドまたはスルホンアミド
|
|
SI1549638T1
(sl)
|
2002-10-03 |
2008-02-29 |
Hoffmann La Roche |
Indol-3-karboksiamidi kot aktivatorji glukokinaze(gk)
|
|
GB0226931D0
(en)
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0226930D0
(en)
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
|
US7132425B2
(en)
|
2002-12-12 |
2006-11-07 |
Hoffmann-La Roche Inc. |
5-substituted-six-membered heteroaromatic glucokinase activators
|
|
ATE506354T1
(de)
|
2003-01-06 |
2011-05-15 |
Lilly Co Eli |
Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
|
|
AU2003294376A1
(en)
|
2003-01-06 |
2004-08-10 |
Eli Lilly And Company |
Heteroaryl compounds
|
|
PL378117A1
(pl)
|
2003-02-11 |
2006-03-06 |
Prosidion Limited |
Tricyklopodstawione związki amidowe
|
|
US7262196B2
(en)
|
2003-02-11 |
2007-08-28 |
Prosidion Limited |
Tri(cyclo) substituted amide glucokinase activator compounds
|
|
PE20050194A1
(es)
|
2003-02-13 |
2005-04-23 |
Banyu Pharma Co Ltd |
Derivados de piridina-2-carboxamida como activadores de glucoquinasa
|
|
MXPA05009059A
(es)
*
|
2003-02-26 |
2005-10-19 |
Banyu Pharma Co Ltd |
Derivados de heteroarilcarbamoilbenceno.
|
|
TW201018661A
(en)
*
|
2003-03-14 |
2010-05-16 |
Ono Pharmaceutical Co |
Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
|
|
AR043633A1
(es)
|
2003-03-20 |
2005-08-03 |
Schering Corp |
Ligandos de receptores de canabinoides
|
|
CA2518823A1
(en)
|
2003-03-24 |
2004-10-07 |
F.Hoffmann-La Roche Ag |
Benzyl-pyridazinons as reverse transcriptase inhibitors
|
|
CN102584813B
(zh)
|
2003-05-14 |
2016-07-06 |
Ngc药物公司 |
化合物及其在调节淀粉样蛋白β中的用途
|
|
US20070099884A1
(en)
|
2003-06-06 |
2007-05-03 |
Erondu Ngozi E |
Combination therapy for the treatment of diabetes
|
|
WO2005028452A1
(en)
|
2003-09-22 |
2005-03-31 |
Pfizer Limited |
Substituted triazole derivatives as oxytocin antagonists
|
|
EP1675844A1
(en)
|
2003-10-23 |
2006-07-05 |
Sterix Limited |
Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
|
|
GB0325402D0
(en)
*
|
2003-10-31 |
2003-12-03 |
Astrazeneca Ab |
Compounds
|
|
US20050171172A1
(en)
*
|
2003-11-13 |
2005-08-04 |
Ambit Biosciences Corporation |
Amide derivatives as PDGFR modulators
|
|
EP1532980A1
(en)
|
2003-11-24 |
2005-05-25 |
Novo Nordisk A/S |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
|
|
GB0327760D0
(en)
|
2003-11-29 |
2003-12-31 |
Astrazeneca Ab |
Compounds
|
|
GB0327761D0
(en)
|
2003-11-29 |
2003-12-31 |
Astrazeneca Ab |
Compounds
|
|
GB0328178D0
(en)
|
2003-12-05 |
2004-01-07 |
Astrazeneca Ab |
Compounds
|
|
BRPI0418212A
(pt)
|
2003-12-29 |
2007-04-27 |
Banyu Pharma Co Ltd |
composto ou um sal deste farmaceuticamente aceitável, ativador da glicocinase, e, medicamentos para a terapia e/ou prevenção da diabete, e da obesidade
|
|
MXPA06007667A
(es)
|
2004-01-06 |
2006-09-01 |
Novo Nordisk As |
Heteroaril-ureas y su uso como activadores de glucocinasa.
|
|
US20080280872A1
(en)
*
|
2004-02-18 |
2008-11-13 |
Craig Johnstone |
Benzamide Derivatives and Their Use as Glucokinase Activating Agents
|
|
CA2554686A1
(en)
|
2004-02-18 |
2005-09-01 |
Astrazeneca Ab |
Compounds
|
|
AU2005223610B2
(en)
|
2004-03-23 |
2008-05-29 |
Banyu Pharmaceutical Co., Ltd. |
Substituted quinazoline or pyridopyrimidine derivative
|
|
JP2007530631A
(ja)
|
2004-04-02 |
2007-11-01 |
ノバルティス アクチエンゲゼルシャフト |
チアゾロピリジン誘導体、それを含む医薬組成物およびグルコキナーゼ介在性状態の処置法
|
|
ATE524479T1
(de)
|
2004-04-02 |
2011-09-15 |
Novartis Ag |
Sulfonamidthiazolpyridinderivate als zur behandlung von typ-2-diabetes geeignete glucokinaseaktivatoren
|
|
MXPA06012008A
(es)
|
2004-04-21 |
2007-01-25 |
Prosidion Ltd |
Compuestos de amida tri(ciclo) sustituidos.
|
|
TW200600086A
(en)
|
2004-06-05 |
2006-01-01 |
Astrazeneca Ab |
Chemical compound
|
|
WO2005123132A2
(en)
|
2004-06-17 |
2005-12-29 |
Novo Nordisk A/S |
Use of liver-selective glucokinase activators
|
|
GB0418046D0
(en)
|
2004-08-12 |
2004-09-15 |
Prosidion Ltd |
Eantioselective process
|
|
GB0418058D0
(en)
|
2004-08-12 |
2004-09-15 |
Prosidion Ltd |
Fluorination process
|
|
CN101035767A
(zh)
|
2004-08-12 |
2007-09-12 |
普洛希典有限公司 |
被取代的苯乙酰胺及其作为葡糖激酶激活剂的用途
|
|
TWI400232B
(zh)
|
2004-09-13 |
2013-07-01 |
Ono Pharmaceutical Co |
含氮雜環衍生物及以該含氮雜環衍生物為有效成分之藥劑
|
|
KR20070085371A
(ko)
|
2004-10-16 |
2007-08-27 |
아스트라제네카 아베 |
페녹시 벤즈아미드 화합물의 제조 방법
|
|
GB0423044D0
(en)
|
2004-10-16 |
2004-11-17 |
Astrazeneca Ab |
Compounds
|
|
GB0423043D0
(en)
|
2004-10-16 |
2004-11-17 |
Astrazeneca Ab |
Compounds
|
|
DE602004018552D1
(de)
|
2004-12-24 |
2009-01-29 |
Telecom Italia Spa |
Verfahren zur optimierung des webseitenzugangs in drahtlosen netzwerken
|
|
EP1874769B1
(de)
|
2005-04-25 |
2011-09-14 |
Merck Patent GmbH |
Neuartige aza-heterozyklen als kinase-inhibitoren
|
|
JP2008542247A
(ja)
|
2005-05-24 |
2008-11-27 |
アストラゼネカ アクチボラグ |
グルコキナーゼモジュレーターとしての２−フェニル置換イミダゾール［４，５ｂ］ピリジン／ピラジンおよびプリン誘導体
|
|
TW200714597A
(en)
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
|
NZ575512A
(en)
*
|
2005-07-09 |
2009-11-27 |
Astrazeneca Ab |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
|
US20080234273A1
(en)
|
2005-07-09 |
2008-09-25 |
Mckerrecher Darren |
Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes
|
|
US20110053910A1
(en)
|
2005-07-09 |
2011-03-03 |
Mckerrecher Darren |
2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
|
|
EP1915367A1
(en)
|
2005-08-09 |
2008-04-30 |
AstraZeneca AB |
Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
|
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
|
TW200800872A
(en)
|
2005-09-07 |
2008-01-01 |
Plexxikon Inc |
PPAR active compounds
|
|
JP2009508832A
(ja)
|
2005-09-16 |
2009-03-05 |
アストラゼネカ アクチボラグ |
グルコキナーゼ活性化剤としてのヘテロ二環式化合物
|
|
WO2007053657A1
(en)
|
2005-11-01 |
2007-05-10 |
Janssen Pharmaceutica N.V. |
Substituted pyrrolones as allosteric modulators of glucokinase
|
|
TW200738621A
(en)
|
2005-11-28 |
2007-10-16 |
Astrazeneca Ab |
Chemical process
|
|
AU2007225836A1
(en)
|
2006-03-10 |
2007-09-20 |
Ono Pharmaceutical Co., Ltd. |
Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
|
|
TW200825063A
(en)
|
2006-10-23 |
2008-06-16 |
Astrazeneca Ab |
Chemical compounds
|
|
SA07280576B1
(ar)
|
2006-10-26 |
2011-06-22 |
استرازينيكا ايه بي |
مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز
|
|
AR064625A1
(es)
|
2006-12-21 |
2009-04-15 |
Astrazeneca Ab |
Forma cristalina de 3-{[5-(azetidin-1-ilcarbonil)pirazin-2-il]oxi}-5-[(1-metiletil)oxi]-n-1h-pirazol-3-ilbenzamida
|